Cagrilintide Research: What is Cagrilintide? How does it work?
The Obesity Epidemic
Obesity has become one of the most pressing public health challenges in the United States and around the world. In the U.S., about 42% of adults are classified as obese, a figure that has nearly tripled over the past 50 years. Globally, over 650 million people are classified as obese, and this number continues to rise rapidly. Obesity increases the risk for many serious health conditions, including heart disease, type 2 diabetes, stroke, and certain cancers, making it a major contributor to premature death and disability worldwide.
Obesity is difficult to control due to several complex factors. It’s not simply a matter of overeating or lack of exercise; rather, it stems from a mix of genetics, hormonal imbalances, metabolism, and environmental factors, such as the easy availability of high-calorie foods and increasingly sedentary lifestyles. This complexity makes it challenging to address basic "eat less, move more" strategies. Additionally, many individuals struggle with yo-yo dieting, where initial weight loss is followed by weight regain once normal eating patterns resume. This cycle makes maintaining weight loss over the long term even more difficult. Furthermore, the medications currently available for weight loss often have limited effectiveness and can come with side effects, making them less appealing for long-term use. Most of these drugs only target specific aspects of obesity, like appetite suppression or metabolism, which doesn't fully address the root causes of the issue.
